Literature DB >> 7593454

Disparate effects of weight reduction by diet on serum dehydroepiandrosterone-sulfate levels in obese men and women.

D J Jakubowicz1, N A Beer, R M Beer, J E Nestler.   

Abstract

To assess the effect of weight reduction on serum dehydroepiandrosterone (DHEA)-sulfate, insulin, and glucose, these parameters were assessed in 18 men and 29 women before and after weight loss achieved by a 2-month 1000-1400 kcal diet. Men and women did not differ at baseline with respect to age, body mass index (BMI), or serum insulin and glucose, but serum DHEA-sulfate was almost 2-fold higher in women than men (5.4 +/- 0.5 vs. 2.8 +/- 0.2 mumol/L; P < 0.001). During the diet, men and women experienced similar reductions in BMI of 3.5 kg/m2 and 3.2 kg/m2, respectively. Fasting serum insulin fell by 38% in men and 33% in women, and did not differ between sexes at the diet's end (135 +/- 7 vs. 156 +/- 8 pmol/L; P = NS). Serum glucose fell slightly in both men and women, but did not differ between sexes. Weight loss in men was associated with a 125% rise in serum DHEA-sulfate from 2.8 +/- 0.2 to 6.3 +/- 0.3 mumol/L (P < 0.0001). In contrast, serum DHEA-sulfate did not change with weight loss in women (P = 0.35). Serum DHEA-sulfate at the end of the diet did not differ between men and women (6.3 +/- 0.3 vs. 5.2 +/- 0.5 mumol/L; P = 0.10). Hence, dietary weight loss accompanied by equivalent reductions in body mass index and serum insulin between sexes was associated with a marked rise in serum DHEA-sulfate in men, whereas in women serum DHEA-sulfate did not change. Although speculative, these findings are consistent with the idea that insulin acts in a sex-specific fashion to reduce circulating DHEA-sulfate in men only.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7593454     DOI: 10.1210/jcem.80.11.7593454

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels.

Authors:  E Mazza; M Maccario; J Ramunni; C Gauna; A Bertagna; A M Barberis; S Patroncini; M Messina; E Ghigo
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women.

Authors:  S Savastano; A Belfiore; B Guida; L Angrisani; F Orio; T Cascella; F Milone; F Micanti; G Saldalamacchia; G Lombardi; A Colao
Journal:  J Endocrinol Invest       Date:  2005-06       Impact factor: 4.256

Review 3.  Adrenal hyperandrogenism in the pathophysiology of polycystic ovary syndrome.

Authors:  E Carmina; R A Lobo
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

Review 4.  Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: from a complex constellation to a simple sequence of prenatal onset.

Authors:  L Ibáñez; F de Zegher; N Potau
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

5.  Effects of 3-month nifedipine treatment on endocrine-metabolic parameters in patients with abdominal obesity and mild hypertension.

Authors:  M Maccario; S E Oleandri; E Avogadri; R Rossetto; S Grottoli; M Procopio; F Camanni; E Ghigo
Journal:  J Endocrinol Invest       Date:  1998-01       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.